The latest review published in the "World Journal of Clinical Cases" summarizes the latest research and recommendations on the bone disease in patients suffering from chronic pancreatitis.

The high incidence of bone disease (osteopenia or osteoporosis) has significantly raised the global healthcare burden. It is related to significant morbidity and mortality rates. The screening techniques like dual-energy X-ray absorptiometry scans have significantly reduced the risk of osteoporotic fractures by early recognition and treatments to improve bone health. The presence of bone disease in various disorders of the gastrointestinal (GI) tract has already been identified, due to which guidelines to screen patients with GI disorders (celiac disease or inflammatory bowel disease) for change in bone mineral density have been formulated.

Patients with chronic pancreatitis sharing similar risk factors to patients with GI disorders have been reported to be at greater risk of bone disease. This is the reason why various studies estimating the incidence and risk of bone disease or fractures in CP patients are being conducted.